PMC:7212965 / 36926-37148
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T80 | 132-138 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T176 | 213-221 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T291 | 8-11 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T292 | 132-138 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
| T293 | 174-177 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T57 | 83-101 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
| T58 | 103-113 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
| T59 | 162-173 | Chemical | denotes | favipiravir | http://purl.obolibrary.org/obo/CHEBI_134722 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T231 | 0-222 | Sentence | denotes | The FDA has issued an emergency use authorization for 3 therapies: choloroquine or hydroxychloroquine, remdesivir, and convalescent plasma.82 In China and Japan, favipiravir has been approved for the treatment of COVID-19. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 935 | 67-79 | Chemical | denotes | choloroquine | |
| 936 | 83-101 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
| 937 | 103-113 | Chemical | denotes | remdesivir | MESH:C000606551 |
| 938 | 162-173 | Chemical | denotes | favipiravir | MESH:C462182 |
| 940 | 213-221 | Disease | denotes | COVID-19 | MESH:C000657245 |